Abstract
Nowhere is the gap between public perception and medical reality as great as in the realm of cancer prevention and treatment. Although cardiovascular disease is by far the greatest threat to the average American, surveys have shown that Americans feel they can control their heart disease. They understand it. It’s rather like plumbing and drains after all.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
arfinkel L: Guest editorial: Preventing cancer. MetLife Statistical Bulletin April-June 1986.
Slovic P: Public perception of risk. Risk Management. March 1992, cited in Medical Benefits, May 30,1992, p. 9.
Chase M: Medical quandry: Breast cancer patients seeking new therapy face tough obstacles. Wall Street Journal vol. 221, no. 32,1993, p. 1.
American Cancer Society Fact Book, 1993.
Brown ML: The national economic burden of cancer: An update. J. National Cancer Institute 1990; 82:1811–1814.
Riley G, et al.: The use and costs of medicare services by cause of death. Inquiry 1987; 24: 233–244.
McCarthy ME, Emerging Geriatric Markets. PJB: London, 1983.
Our estimate of potential decline based on data from Changing Population Age Structures 1990-2015. United Nations: Geneva, 1992.
Finter L: Cancer rates in Florida spark strong competition. Journal of the National Cancer Institute, 1990; 83:1704–1706.
Moertel CG: Off-label drug use for cancer therapy and national health care priorities. Journal of the American Medical Association 1991; 266: 3031,3032.
Mortenson LE: Study supports widespread off-label drug use, compendia’s ability to impact reimbursement. Oncology Issues. Summer 1993; 7:3,21.
Rosenberg SA. et al.: Observations on the systemic administration of autologous lyphokine activated killer cells and recombinant inter-leukin-2 in patients with metastatic cancer. New England Journal of Medicine 1985; 313: 1485–1492.
McCabe MS, Stabiein D, and Hawkins MS: The modified group C experience with phase III randomized trials in renal cell carcinoma and advanced melanoma. PNAS 1991; 10: 213.
Laetz T: Reimbursement policies constrain the practice of oncology. Journal of the American Medical Association 1991; 226: 2996–2999.
Jaakkimainin L, et al.: Counting the costs of chemotherapy in a national cancer institute of canada randomized trial in nonsmall-cell lung cancer. J. Clinical Oncology 1990; 8:1301–1308.
Raffin T: Intensive care unit survival of patients with systemic illness. Am. Review Respiratory Diseases 1989; 140: 528–535.
New York Times. March 21,1993, p. 27. Cited in Journal of the American Medical Association study.
Duffy TP: Yale J. of Biology and Medicine 1992; 65: 75–82.
Canadian national breast screening study: 1—Breast cancer detection and death rates among women aged 40-49 years. Canadian Medical Association J. 1992; 147:1459–1476.
Idem: Canadian national breast screening study: 2—Breast cancer detection and death rates among women aged 50-59 years. Canadian Medical Association J 1477–1488.
Optenberg S and Thompson I: Economics of screening for carcinoma of the prostate. Urologic Clinics of North America 1990; 17: 4.
Smith P: The case for no initial treatment. Urologie Clinics of North America 1990; 17: 4
McCusker J, Stoddard M, and Sorenson AA: Do HMOs reduce hospitalization of terminal cancer patients. Inquiry 1988; 25: 263–270.
Rights and permissions
Copyright information
© 1994 Humana Press Inc.
About this chapter
Cite this chapter
Cundiff, D., McCarthy, M.E. (1994). Cancer—Denying Reality. In: The Right Medicine. Humana Press. https://doi.org/10.1007/978-1-4612-0309-4_3
Download citation
DOI: https://doi.org/10.1007/978-1-4612-0309-4_3
Publisher Name: Humana Press
Print ISBN: 978-0-89603-284-2
Online ISBN: 978-1-4612-0309-4
eBook Packages: Springer Book Archive